Yucai Wang

88PUBLICATIONS
352CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyDisease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (88)

|Aug 20, 2026
Malignant B-cell States Orchestrate Spatially Organized Immune Ecosystems in B-cell Lymphomas.

|Jul 23, 2026
Autologous Stem Cell Transplant Consolidation Is Associated With Improved Overall Survival in Angioimmunoblastic T-Cell Lymphoma: A Real-World National Cancer Database Study.

|Jun 24, 2026
No Association of Prior Administration of Selected Vaccines with Lymphoma Prognosis.

|Jun 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Apr 21, 2026
Lymphocyte dynamics after CAR-T therapy for non-Hodgkin lymphoma.

Pageof 15

Frequent Collaborators

27 joint publications

Matthew Maurer

26 joint publications

James R Cerhan

24 joint publications

Thomas E Witzig

23 joint publications

Stephen M Ansell